Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells.
Hyperthyroidism is associated with increased bone resorption but the mechanisms by which thyroid hormone (T3) affects bone cell metabolism remain unclear. Recently it has been suggested that T3 stimulates osteoclastic resorption indirectly through the release of soluble mediators from osteoblasts. The aim of the present study was to investigate whether the T3-induced increase in bone resorption could be due to the regulation of cytokine production by human osteoblasts (hOb). The effects of T3 (1, 10, 100 nM) and IL-1 beta (100 U/ml) as the positive control were examined on cytokine protein release and mRNA levels in cultured hOb cell lines (MG63, SaOs-2), primary hOb and human bone marrow stromal (hBMS) cells. T3 increased IL-6 and IL-8 mRNA levels as well as IL-6 and IL-8 protein release into the culture media from MG63 and hBMS cells in a time- and dose-dependent manner. The maximal effect on protein release in hBMS cells occurred at 24 h with a dose of T3 10 nM (IL-6 5.5 +/- 1.1-fold above controls; IL-8 3.7 +/- 0.5-fold above controls, P < 0.05). At the same time, mRNA levels in hBMS cells were increased 6.2 +/- 0.8-fold for IL-6 (P < 0.05) and 5.7 +/- 0.8-fold for IL-8 (P < 0.05). Similar results were obtained in MG63 cells but no response was seen in SaOs-2 or hOb cells despite measurable basal production. Nor was there detectable regulation of IL-1 beta, IL-3, IL-11, IL-4 or granulocyte macrophage-colony stimulating factor by T3 in any cell type. In conclusion, T3 increases IL-6 and IL-8 production by MG63 and hBMS cells, suggesting that IL-6 and IL-8 may be T3-regulated genes in osteoblasts.
Department of Clinical Biochemistry, St Bartholomew's, Whitechapel, London, UK.
A
A
Siddiqi
J M
JM
Burrin
D F
DF
Wood
J P
JP
Monson
D001854:Bone Marrow Cells / Q000187:drug effects / Q000378:metabolism*; D001862:Bone Resorption; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D015850:Interleukin-6 / Q000096:biosynthesis* / Q000235:genetics; D016209:Interleukin-8 / Q000096:biosynthesis* / Q000235:genetics; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis; D013268:Stimulation, Chemical; D013997:Time Factors; D014284:Triiodothyronine / Q000494:pharmacology*
D007375:Interleukin-1; D015850:Interleukin-6; D016209:Interleukin-8; D012333:RNA, Messenger; D014284:Triiodothyronine